Exogenous Platelet-Derived Growth Factor (PDGF) induces human astrocytoma cell line proliferation

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2161-2166

  Ranza, E ^a   Facoetti, Angelica ^a,b   Morbini, P ^c   Benericetti, E ^d   Nano, R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b INFN SEZIONE DI PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

Author keywords

Astrocytoma; PDGF; PDGF receptor; Platelet derived growth factor; Proliferation

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

ARTICLE; ASTROCYTOMA; ASTROCYTOMA CELL; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ASTROCYTOMA; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 34547757537     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Seedorf K: Intracellular signaling by growth factors. Metabolism 44: 24-32, 1995.
2. Hunter T: Oncoprotein networks. Cell 88: 333-346, 1997.
3. Marshall CJ: Specifity of receptor tyrosine kinase signaling: Transient versus substained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995.
4. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
5. Al-Obeidi FA and Lam KS: The protein tyrosine kinase family of the human genome. Oncogene 19: 5548-5557, 2000.
6. Shih AH and Holland EC: Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett 232: 139-147, 2006.
7. Klominek J, Baskin B and Hauzenberger D: Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor β-integrin α3β1 interaction. Clin Exp Metastasis 16: 529-539, 1998.
8. Raines EW and Ross R: Platelet-derived growth factor in vivo. In: Biology of Platelet-derived Growth Factor. Westermark B and Sorg C (eds.). Basel, Karger, pp. 74-114, 1993.
9. Nister M, Claesson-Welsh L, Eriksson A, Heldin CH and Weestermark B: Differential expression of platelet-derived growth factor receptor in human malignant glioma cell lines. J Biol Chem 266: 16755-16763, 1991.
10. Matsumoto H, Nasu K, Nishida M, Ito H, Bing S and Miyakawa I: Regulation of proliferation, mobility, and contractility of human endometrial stromal cells by platelet-derived growth factor. J Clin Endocrinol Metab 90: 3560-3567, 2005.
11. Ostman A and Heldin CH: Involvement of platelet-derived growth factor in disease: development of specific antagonists. Adv Cancer Res 80: 1-38, 2001.
12. Tallquist M and Kazlaushas A: PDGF signalling in cells and mice. Cytokine Growth Factor Rev 15: 205-213, 2004.
13. Heldin CH, Westermark B and Wastenson A: Specific receptors for platelet-derived growth factor in cells derived from connective tissue and glia. Proc Natl Acad Sci USA 78: 3664-3668, 1981.
14. Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM and Antoniades HN: Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86: 131-140, 1990.
15. Preusser M, Haberler C and Hainfellner JA: Malignant glioma: neuropathology and neurobiology. Wien Med Wochenschr 11-12: 332-337, 2006.
16. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW and Burger PC: Histopathology, classification, and grading of gliomas. Glia 15: 211-221, 1995.
17. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG and Vertosick FT: Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium. J Neurosurg 73: 106-112, 1990.
18. Bacciocchi G, Gibelli N, Zibera C, Pedrazzoli P, Bergamaschi G, De Piceis Polver P, Danova M, Mazzini G, Palomba L, Tupler R and Robustelli Delia Cuna G: Establishment and characterization of two cell lines derived from human glioblastoma multiforme. Anticancer Res 3: 853-861, 1992.
19. Akbasak A and Sunar-Akbasak B: Oncogenes: cause or consequence in the development of glial tumours. J Neurol Sci 111: 119-133, 1992.
20. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B and Nister M: Platelet-derived growth factor and its receptor in human glima tissue: expression of messanger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52: 3213-3219, 1992.
21. van der Valk P, Lindeman J and Kamphorst W: Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma? Ann Oncol 8: 1023-1029, 1997.
22. Heldin CH and Westermark B: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 4: 1283-1316, 1999.
23. Sorkin A: Endocytosis and intracellular sorting of receptor tyrosine kinases. Front Biosci 3: 729-738, 1998.
24. Di Fiore PP and Kraus MH: Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia. Cancer Treat Res 61: 139-160, 1992.